EXC
54
-2
GIS
26
3
HRL
39
15
CSX
51
-2
DE
46
3
PPL
54
2
TGNA
53
2
WDC
41
-2
SYF
85
2
JNJ
41
2
NRG
49
-3
PVH
52
-3
AVGO
20
-5
DHI
48
3
SRE
63
-3
ZTS
47
2
APA
21
2
NWSA
62
2
ZBH
60
-2
AIV
68
-4
EXC
54
-2
GIS
26
3
HRL
39
15
CSX
51
-2
DE
46
3
PPL
54
2
TGNA
53
2
WDC
41
-2
SYF
85
2
JNJ
41
2
NRG
49
-3
PVH
52
-3
AVGO
20
-5
DHI
48
3
SRE
63
-3
ZTS
47
2
APA
21
2
NWSA
62
2
ZBH
60
-2
AIV
68
-4
Financhill
Back

BioNTech SE Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44

BNTX
BioNTech SE

Last Price:
108.36
Seasonality Move:
3.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

BioNTech SE Price Quote

$108.36
+6.22 (+6.09%)
(Updated: November 21, 2024 at 5:55 PM ET)

BioNTech SE Key Stats

Sell
44
BioNTech SE (BNTX) is a Sell
Day range:
$101.02 - $105.82
52-week range:
$76.53 - $131.49
Dividend yield:
0%
P/E ratio:
24.57
P/S ratio:
7.44
P/B ratio:
1.14%
Volume:
1.1M
Avg. volume:
919.2K
1-year change:
3.35%
Market cap:
$24.4B
Revenue:
$4.1B
EPS:
$-2.11

How Much Does BioNTech SE Make?

Is BioNTech SE Growing As A Company?

  • What Is BioNTech SE's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.4%
  • What Is BioNTech SE's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.24%

BioNTech SE Stock Price Performance

  • Did BioNTech SE Stock Go Up Last Month?
    BioNTech SE share price went down by -8.62% last month
  • Did BNTX's Share Price Rise Over The Last Year?
    BNTX share price rose by 3.35% over the past 1 year

What Is BioNTech SE 52-Week High & Low?

  • What Is BioNTech SE’s 52-Week High Share Price?
    BioNTech SE has traded as high as $131.49 over the past 52 weeks
  • What Is BioNTech SE’s 52-Week Low Share Price?
    BioNTech SE has traded as low as $76.53 over the past 52 weeks

BioNTech SE Price To Free Cash Flow

Is It Risky To Buy BioNTech SE?

  • How Much Debt Does BioNTech SE Have?
    Total long term debt quarterly is $272.2M
  • How Much Cash Does BioNTech SE Have?
    Cash and short term investments quarterly total is $18.7B
  • What Is BioNTech SE’s Book Value Per Share?
    Book value per share is 89.05

Is BioNTech SE Cash Flow Positive?

  • What Is BNTX Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.6B
  • What Is BioNTech SE’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$51.7M
  • What Is BioNTech SE’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$5.8B

BioNTech SE Return On Invested Capital

  • Is Management Doing A Good Job?
    BNTX return on invested capital is -2.32%
  • What Is BioNTech SE Return On Assets?
    ROA measures how assets are converting to revenues and is -2.06%
  • What Is BNTX Return On Equity?
    ROE is a measure of profitability and is -2.35%

BioNTech SE Earnings Date & Stock Price

  • What Is BioNTech SE's Stock Price Today?
    A single share of BNTX can be purchased today for 102.14
  • What Is BioNTech SE’s Stock Symbol?
    BioNTech SE trades on the nasdaq under the ticker symbol: BNTX
  • When Is BioNTech SE’s Next Earnings Date?
    The next quarterly earnings date for BioNTech SE is scheduled on March 20, 2025
  • When Is BNTX's next ex-dividend date?
    BioNTech SE's next ex-dividend date is June 2, 2022
  • How To Buy BioNTech SE Stock?
    You can buy BioNTech SE shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

BioNTech SE Competitors

  • Who Are BioNTech SE's Competitors?
    Below is a list of companies who compete with BioNTech SE or are related in some way:
    • Akari Therapeutics PLC (AKTX)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • DBV Technologies SA (DBVT)
    • NuCana PLC (NCNA)
    • Novavax Inc (NVAX)

BioNTech SE Dividend Yield

BioNTech SE Analyst Estimates

YoY Growth Past Surprise
EPS: 23.97% 150.43%
Revenue: 40.45% 141.23%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 134.85
Upside from Last Price: 32.02%

Major Shareholders

  • How many BNTX shares are owned by institutional investors?
    167.6M BNTX shares are owned by institutional investors
  • How many BNTX shares are owned by insiders?
    0 BNTX shares are owned by insiders